Geneos Wealth Management’s Innovator Defined Wealth Shield ETF BALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$35K Sell
1,000
-7,246
-88% -$251K ﹤0.01% 1864
2026
Q2
$283K Buy
+8,246
New +$281K 0.01% 882
2025
Q4
– Sell
-2,754
Closed -$90.4K – 2468
2025
Q3
$90.4K Buy
+2,754
New +$89.4K ﹤0.01% 1157

Other funds holding BALT

Geneos Wealth Management's BALT Position: Q3 2026 in Review

Geneos Wealth Management reduced its Innovator Defined Wealth Shield ETF (BALT) stake by 88% in Q3 2026, selling an estimated $251K and leaving 1,000 shares worth $35K. The position accounts for ﹤0.01% of the portfolio, ranked #1864.

Geneos Wealth Management first reported a position in BALT in Q3 2025 and has held it in 3 quarters since. The position peaked at $283K in Q2 2026. 298 funds tracked by Wall St. Rank hold BALT as of Q3 2026.

  • Geneos Wealth Management held 1,000 shares of Innovator Defined Wealth Shield ETF worth $35K as of Q3 2026.
  • Geneos Wealth Management sold 7,246 Innovator Defined Wealth Shield ETF shares in Q3 2026, an estimated $251K.
  • Innovator Defined Wealth Shield ETF made up ﹤0.01% of Geneos Wealth Management's portfolio in Q3 2026, its #1864 holding.
  • Geneos Wealth Management first reported a position in Innovator Defined Wealth Shield ETF in Q3 2025 and has held it in 3 quarters since.
  • Geneos Wealth Management's Innovator Defined Wealth Shield ETF position peaked at $283K in Q2 2026.
  • 298 funds tracked by Wall St. Rank held Innovator Defined Wealth Shield ETF as of Q3 2026.

Based on Geneos Wealth Management's 13F filing for Q3 2026, filed 9 Nov 2026.